A Substantial Response from Adding Palbociclib to Endocrine Therapy in Brain Metastasis from Hormone Receptor-Positive, HER2-Negative Breast Cancer: Case Reports

Brain metastasis (BM) from breast cancer has poor prognosis despite new advances and multi-modality treatments. No current data is guiding the use of palbociclib in the management of hormone receptor (HR)-positive breast cancer patients with BM as these patients were excluded systematically from all...

Descripción completa

Detalles Bibliográficos
Autores principales: Abusanad, Atlal, Al Hashem, Hashem
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7983625/
https://www.ncbi.nlm.nih.gov/pubmed/33790765
http://dx.doi.org/10.1159/000514190

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7983625/
https://www.ncbi.nlm.nih.gov/pubmed/33790765
http://dx.doi.org/10.1159/000514190

Ejemplares similares